Patents by Inventor Lincoln J. McBride

Lincoln J. McBride has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6054266
    Abstract: Nucleic acid sequences are detected by a multi-step process, involving labeling sample nucleic acid sequences, duplexing the labeled sample with a probe having a coupling element, immobilizing all of the duplexed probe and target sequence and unduplexed probe, separating specifically immobilized nucleic acid from free and non-specifically immobilized nucleic acid, releasing specifically immobilized nucleic acid, and detecting the presence of the sequence of interest by means of the label. The labeled sequence may be characterized by sizing, e.g. electrophoresis. The method provides for a sensitive and rapid means for accurate detection of sequences of interest in a wide variety of situations.
    Type: Grant
    Filed: November 23, 1988
    Date of Patent: April 25, 2000
    Assignee: Applied Biosystems, Inc.
    Inventors: Mel N. Kronick, Douglas H. Keith, Lincoln J. McBride, Norman M. Whiteley, Michael W. Hunkapiller
  • Patent number: 5928907
    Abstract: A system is provided for carrying out real time fluorescence-based measurements of nucleic acid amplification products. In a preferred embodiment of the invention, an excitation beam is focused into a reaction mixture through a surface, the reaction mixture containing (i) a first fluorescent indicator capable of generating a first fluorescent signal whose intensity is proportional to the amount of an amplification product in the volume of the reaction mixture illuminated by the excitation beam and (ii) a second fluorescent indicator homogeneously distributed throughout the reaction mixture capable of generating a second fluorescent signal proportional to the volume of reaction mixture illuminated by the excitation beam. Preferably, the excitation beam is focused into the reaction mixture by a lens through a portion of a wall of a closed reaction chamber containing the reaction mixture.
    Type: Grant
    Filed: December 2, 1996
    Date of Patent: July 27, 1999
    Assignee: The Perkin-Elmer Corporation., Applied Biosystems Division
    Inventors: Timothy M. Woudenberg, Kevin S. Bodner, Charles R. Connell, Alan M. Ganz, Lincoln J. McBride, Paul G. Saviano, John Shigeura, David H. Tracy, Eugene F. Young, Linda G. Lee
  • Patent number: 5736333
    Abstract: The invention relates to passive internal references for use in quantitating the formation of amplification products in a nucleic amplification reaction. The internal amplification reference molecules of the invention comprise a first and second fluorophore joined together through a backbone connector. The first and second fluorophores are joined on the backbone in a configuration that permits the energy transfer from the first fluorophore to the second fluorophore. The backbone connector is selected so as not to bind to the target nucleic acid sequence under nucleic acid amplification conditions. Preferably, the backbone connector is a polynucleotide. Another aspect of the invention is to provide passive internal reference molecule containing reagent compositions for use in nucleic acid amplification reactions. The compositions comprise the internal amplification reference molecule of the invention and a nucleic acid amplification reaction buffer.
    Type: Grant
    Filed: June 4, 1996
    Date of Patent: April 7, 1998
    Assignee: The Perkin-Elmer Corporation
    Inventors: Kenneth J. Livak, Lincoln J. McBride
  • Patent number: 5443791
    Abstract: A liquid-handling instrument has a worksurface with registration for modular stations to support containers of liquid, pipette apparatus with a pipette tip coupled to a sensing circuit, a robotic translation system for moving the pipette tip, and a control system with an iconic user interface for programming and editing. A gauge block registered on the worksurface provides for calibration using the sensing tip, and register cavities on the worksurface provide for modular stations. There is a wash station fop the pipette tip on the worksurface. An automated laboratory based on the liquid-handling system has heating and cooling and a sealable incubation station as well as a magnetic separation station. Methods are disclosed using the apparatus to convey droplets of liquid, to aspirate with minimum tip contamination, to mix liquids in containers, and to validate the worksurface.
    Type: Grant
    Filed: August 7, 1992
    Date of Patent: August 22, 1995
    Assignee: Perkin Elmer - Applied Biosystems Division
    Inventors: G. Richard Cathcart, Thomas Brennan-Marquez, John A. Bridgham, George S. Golda, Harry A. Guiremand, Marianne Hane, Louis B. Hoff, Eric Lachenmeier, Melvyn N. Kronick, Douglas H. Keith, Paul E. Mayrand, Michael L. Metzker, William J. Mordan, Lincoln J. McBride, John Shigeura, Chen-Hanson Ting, Norman M. Whiteley
  • Patent number: 5093245
    Abstract: Termini of restricted double-stranded DNA fragments are modified by ligating the fragments with terminal phosphate-free double-stranded oligonucleotides having a complementary terminus in the presence of a restriction enzyme and a ligase, where joining of the complementary ends results in loss of the restriction enzyme recognition sequence.
    Type: Grant
    Filed: January 26, 1988
    Date of Patent: March 3, 1992
    Assignee: Applied Biosystems
    Inventors: Douglas H. Keith, Mel N. Kronick, Lincoln J. McBride, Norman M. Whiteley
  • Patent number: 4816571
    Abstract: A method is provided for capping failure sequences in oligonucleotide synthesis by phosphitylation. A phosphite monoester is reacted with the 5' or 3' hydroxyl of the failure sequence between successive condensation steps in a synthesis procedure to form a 5' or 3' phosphite diester with the failure sequence. The phosphite diester substituent is inert with respect to subsequent reaction steps in the synthesis of the desired oligonucleotide product.
    Type: Grant
    Filed: June 4, 1987
    Date of Patent: March 28, 1989
    Assignee: Applied Biosystems, Inc.
    Inventors: William A. Andrus, J. William Efcavitch, Lincoln J. McBride